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Background: Although infections represent the most common health problem of travellers abroad, data
on morbidity and incidences of various infections are scarce.
Method: Data on infections of Finnish travellers during 2010e2012 were retrieved from the database of
SOS International, an assistance organization covering 95% of Finns requiring aid abroad. The study
included 30,086 cases. For incidence calculation, the data were linked to the numbers of Finns visiting
these regions during the same period as recorded by the Official Statistics of Finland.
Results: The incidence of infections was particularly high in Africa, southern Europe plus the eastern
Mediterranean, and Asia plus Oceania. The most frequent diagnoses were acute gastroenteritis (38.0%)
and respiratory-tract infections (RTI) (34.5%), followed by infections of the ear (12.6%), skin or subcu-
taneous tissue (5.1%), urogenital tract (4.2%), eye (3.1%), and systemic febrile infections (2.2%). Vaccine-
preventable diseases (VPD) accounted for 0.8% of cases, with varicella as most (49%) and influenza as
second-most (27%) common.
Conclusions: Incidence of infections was higher in southern than in eastern and western Europe.
Gastroenteritis and RTI proved the most frequent diagnoses, whereas systemic febrile infections were
uncommon. Despite pre-travel immunizations, VPDs still occurred; pre-travel consultation should cover
both varicella and influenza.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
International travel has, in recent decades, increased substan-
tially; annual international tourist arrivals are expected by 2030 to
reach 1.8 billion, with travel to emerging economies increasing at
twice the pace of travel to advanced regions [1]. Accordingly,
travellers are anticipated to cause a rising burden on health care
systems both in the regions visited and in their home countries
after return. Over half the visitors to developing countries have
been reported to fall ill, and 8% to requiremedical attention [2]. Lessland; RTI, respiratory-tract
' diarrhoea; VPD, vaccine-
ision of Infectious Diseases,
tal, POB 348, FI-00029 HUS,
iikam€aki), pia.kivela@hus.fi
hus.fi (A. Kantele).data are available on travel to developed countries. Recently, we
showed that more than half of all health problems during travel are
infections [3].
Most studies present the proportionate morbidity of returning
travellers, often reporting data from centres specialized in travel
and tropical medicine [4e15]. As for health problems while abroad,
data have been collected mainly after travellers' return [2,16e20],
with figures recorded during the actual journeys being scarce
[21e23]. Until recently, reports on incidences, meaning cases
related to numbers of travellers to each region, have been lacking
[24].
The largest group among all international travellers are the
Europeans. Even though they represent only 10% of the world
population, they are responsible for half of world's international
arrivals [1]. Our earlier report [3] presented data on 50,710 Finnish
travellers with health problems abroad, as retrieved from an
assistance organization (SOS International) covering 95% of Finns
requiring aid abroad. In addition to presenting proportionate
morbidity, we combined those data with the annual numbers of
H. Siikam€aki et al. / Travel Medicine and Infectious Disease 15 (2017) 29e3630travellers to various destinations that are recorded in the Official
Statistics of Finland (OSF) [25], enabling calculation of incidence of
illness and injury during travel. The study not only found significant
differences in incidences between geographic regions, but also
demonstrated that infections (60%) outnumber all other health
problems. We now revisit these data to study the incidences of
infections in various geographic regions and to examine their types
in more detail.2. Methods
2.1. Assistance organization data
SOS International (SOS), serving Nordic and Baltic insurance
companies, provides travellers with 24-h emergency assistance:
advice, medical evaluation, referral to treatment, cost coverage and
arrangement of transportation if indicated for medical reasons. SOS
covers approximately 95% of all Finnish cases (77% of inpatients,
99.8% of outpatients) handled by assistance organizations of in-
surance companies abroad [3]. The study material covers Finnish
travellers that used health care services abroad and were reported
to SOS. Coordinating doctors are assigned to 86% of inpatient and
1% of outpatient cases [3]. They stay in contact with patient and
clinician abroad, examine medical reports, evaluate treatment, and
give orders for repatriation. Non-medical assistance coordinators
see to the uncomplicated inpatient, and to 99% of outpatient cases,
recording diagnoses provided by clinicians abroad [3]. Earlier, we
retrieved data on all cases, 1 January 2010 to 31 December 2012, a
total of 50,710. For the present study we selected only those cases
diagnosed with infection (Fig. 1).
All SOS data are processed in a computerized database and
comprised information on age, sex, time and country of illness,
inpatient or outpatient status, main diagnosis, repatriation, and
death. Research permission came from SOS.All Finnish travelle
staying at least one night
2010-2012
according to the Official Statisti
14,103,000 travelle
Finnish travellers
seeking medical care a
2010-2012












Fig. 1. Study population and calculation of incidence. a SOS International (SOS), serving Nord
abroad: advice, medical evaluation, referral to treatment, cost coverage, and arrangement o
Finnish cases (77% of inpatients, 99.8% of outpatients) handled abroad by assistance organiz
[3]. c Overnight leisure and business trips abroad; includes travellers 15e74 years of age in2.2. OSF data
The OSF data on Finnish travellers comprise annual numbers
and median duration of at-least-overnight leisure, business and
professional visits abroad, and travellers' age groups by region and
country. The initial data collection included monthly sample-based
computer-assisted telephone interviews with Finnish residents
aged 15e74 years; in 2012, the upper age limit was extended to 84
years. The samples, systematically drawn from the central popu-
lation register, totalled 26,400 individuals annually in 2010 and
2011, and 28,200 in 2012 [25].
2.3. Definitions
A case was defined as a Finnish traveller abroad with one
episode of illness that received a diagnosis of infection, a case
handled by SOS during 2010e2012. Anyone with several separate
episodes was thus counted more than once. Repatriations were
grouped based on manner of return: as planned, by air ambulance,
or by other rearranged transport.
2.4. Diagnoses
Coordinating doctors had encoded the diagnoses, applying the
International Statistical Classification of Diseases and Related
Health Problems 10th revision (ICD-10) [26]. Assistance co-
ordinators had recorded them as open text. For the present study, a
single coordinating doctor, one of the researchers (HS), encoded
these diagnoses applying ICD-10. We separated infection diagnoses
from the ICD-10 organ-specific classification into a category of their
own and classified them further under the following subcategories:
acute gastroenteritis, respiratory tract infections, infections of the
ear, infections of the skin or subcutaneous tissue (dermatologic
infections), infections of the urogenital tract, infections of the eye,













ic and Baltic insurance companies, provides travellers with 24-h emergency assistance
f transportation if indicated for medical reasons. SOS covers approximately 95% of all
ations [3]; records for 2010e2012 were included in this analysis. b Data retrieved from
2010e2011, and travellers 15e84 years of age in 2012 [25].
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Principles of incidence calculation are described in Fig. 1 and
appear in more detail in Supplementary Table 1 and our earlier
report [3]. For compatibility with the OSF population, incidence
calculation was restricted to adults. For incidence calculations, we
modified the geographic classification to make it compatible with
the OSF classification [25]. No incidences appear for the Nordic or
Baltic countries or Russia, because proportionally more cases are
covered by the Social Insurance Institution of Finland (Kela), and
visits are shorter than elsewhere, thus hampering comparisonwith
other regions [3].2.6. Statistical methods
Details of statistical analysis of the incidences and estimation of
the 95% Bayesian credible intervals (BCI) are described in
Supplementary Table 1 and our earlier report [3]. Analysis of
descriptive statistics was with Microsoft Excel 2010 and IBM SPSS
19.0. Differences between groups were tested with chi-squared and
Student's t-tests and the KruskaleWallis test, as appropriate.3. Results
The analysis included 30,086 cases; median age was 40 years
[interquartile range (IQR) 15e59]; 55.7% were women. Most cases
(20,264) were reported in southern Europe plus the eastern Med-
iterranean (Table 1).Table 1
Characteristics of casesa abroad with infection diagnosis, 2010e2012.
Casea characteristics




Median age, years (IQR) 40 (15e59)







Geographic region, n (%)
Europe and eastern Mediterranean 21,104 (69.5)
Southern Europeb 15,406 (50.7)
Eastern Mediterraneanc 4858 (16.0)
Rest of Europed 840 (2.8)
Africa 2586 (8.5)
North Africa 2516 (8.3)
Sub-Saharan Africae 70 (0.2)
Asia and Oceania 6416 (21.1)
Southeast Asia 6081 (20.0)
South central Asiaf 257 (0.8)
Otherg 78 (0.3)
The Americas 280 (0.9)
Central and South America and the Caribbean 220 (0.7)
IQR: interquartile range.
a A case was defined as a Finnish traveller abroad with one episode of illness,
handled by SOS International during 2010e2012. Anyone with several separate
episodes was counted more than once.
b Balkan states, Cyprus, Greece, Italy, Malta, Madeira, Portugal including Madeira,
Spain including Canary Islands.
c Israel, Turkey.
d European countries not included in southern Europe.
e Including South Africa.
f From Pakistan to Bangladesh.
g Western Asia, northeast Asia, Australia, New Zealand, Oceania.3.1. Incidence of infections e general outlines
Infection incidence was greatest in Africa, in southern Europe
plus the easternMediterranean, and in Asia plus Oceania. Incidence
was low in the Americas and in eastern plus western Europe
(Table 2).
Acute gastroenteritis was most common in Africa, respiratory-
tract infections (RTI) in southern Europe and the eastern Mediter-
ranean. Ear, dermatologic, and urogenital infections were most
commonly reported from southern Europe plus the eastern Medi-
terranean or Asia and Oceania. Incidences of urogenital and eye
infections were highest in southern Europe plus the eastern
Mediterranean.
3.2. Proportionate morbidity e overview
Acute gastroenteritis (11,544 cases) proved to be the most
common diagnosis (38%), followed by respiratory tract infections
(35%), infections of the ear (13%), skin or subcutaneous tissue (5%),
urogenital tract (4%), eye (3%), systemic febrile infections (2%), and
other infections (0.2%) (Table 3).
Of all cases, 87% were treated as outpatients and 13% as in-
patients (Table 4); 12% of women and 15% of menwere hospitalized
(p < 0.05). The most common reason for hospital treatment was
acute gastroenteritis (66% of inpatients). Data on duration of hos-
pital stay were incomplete; of the gastroenteritis cases, data were
available for 730 cases with a median duration of 2 days (IQR 1e3).
Patients with gastroenteritis needed hospitalization more often
(23.3%) than did those with RTI (7.1%) (p < 0.05).
Of the ear infection cases, 53% had otitis media, 59% of whom
were under age 15. Of the dermatologic infection cases, 80% were
superficial infections of the skin and subcutaneous tissue. Of all
cases with infection of the ear, skin, urogenital tract, or eye, most
received treatment as outpatients.
Of all cases, 0.8% had a vaccine-preventable disease (VPD) with
varicella as the most common, followed by influenza, herpes zoster,
typhoid fever, and single cases of hepatitis A/B, measles and
mumps. Of the varicella cases, 86% were children under age 15.
3.2.1. Age
When compared to other age groups, the proportion of acute
gastroenteritis was greatest in the age groups 15 to 29, 30 to 44, and
45e59 years (p < 0.05) (Fig. 2), while that of RTI increased with age,
being greatest for those aged 60 to 74 and 75e100 years (p < 0.05).
In children (0e14 years), the proportion of ear infections and sys-
temic febrile infections was larger (p < 0.05), and that of derma-
tologic infections smaller (p < 0.05) than in other age groups.
3.2.2. Sex
The proportion of acute gastroenteritis and ear infections was
greater in men (p < 0.05), whereas women had a higher proportion
of respiratory, urogenital, and eye infections (p < 0.05) (Table 5).
3.2.3. Repatriation and deaths
In 509 (1.7%) cases, the return travel required re-arrangement
(Table 6). Eight cases (0.03%) needed transport by air ambulance.
The data included four deaths: three cases of sepsis, including one
melioidosis, and one pneumonia.
4. Discussion
Whereas numerous studies provide data on proportionate
morbidity from a variety of diseases in travellers, this is e to the
best of our knowledgee the first study to present, in a single report,




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Diagnoses of infection casesa among travellers abroad, 2010e2012.
Diagnoses Total, n (%)
All 30,386 (100)
Acute gastroenteritis, all 11,544 (38.0)
Respiratory tract infections, all 10,475 (34.5)
Upper respiratory tract infections
Acute upper respiratory tract infection 4755
Acute tonsillitis 1003
Acute sinusitis 928
Lower respiratory tract infections
Acute lower respiratory tract infection 3165
Pneumonia 557
Influenza* 67
Ear infections, all 3843 (12.6)
Otitis media 2032
Otitis externa 1811
Dermatologic infections, all 1538 (5.1)
Infection of skin or subcutaneous tissue 1222
Erysipelas or cellulitis 316
Urogenital infections, all 1305 (4.3)
Pyelonephritis or urinary tract infection 1133
Infection of female genital organs 108
Infection of male genital organs 64
Eye infections, all 955 (3.1)
Systemic febrile infections, all 671 (2.2)
Viral infections
Unspecified viral infection 249
Varicella-zoster virus infectionb* 166
Dengue fever 84c
Other specified viral infection 56d
Bacterial infections
Unspecified bacterial infection 85
Sepsis 12
Specified bacterial infection 11e
Parasite infections
Malaria 8f
Other Infections, all 55 (0.2)
Intestinal parasites or ectoparasites 40
Bone or joint infections 8
Sexually transmitted diseases 6g
*Vaccine-preventable disease (n ¼ 240).
a A case was defined as a Finnish traveller abroad with one episode of illness,
handled by SOS International during 2010e2012. Anyone with several separate
episodes was counted more than once.
b Varicella* 118, herpes zoster* 48.
c In southeast Asia 82, in the Americas 2.
d Hand, foot and mouth disease or herpangina 18, mononucleosis 17, viral
meningitis or encephalitis 12, chikungunya 1, exanthema subitum 1, generalized
herpes simplex virus infection 1, hemorrhagic fever with renal syndrome 1, hepa-
titis A* 1, hepatitis B* 1, hepatitis C 1, measles* 1, mumps* 1.
e Typhoid fever* 3, borreliosis 2, scarlatina 2, streptococcal infection 2, bacterial
meningitis 1, pulmonary tuberculosis 1.
f In Africa 7, in Asia 1.
g HIV infection 1.
H. Siikam€aki et al. / Travel Medicine and Infectious Disease 15 (2017) 29e3632visiting different geographic areas. The figures are considered to
represent the most serious cases, i.e. the ones to which pre-travel
advice should focus. Acute gastroenteritis (travellers' diarrhoea,
TD) and RTI were nearly equally common during travel, while
systemic febrile infections proved relatively rare. VPDs were still
found, a point to be considered in pre-travel counseling.
4.1. Incidence of infections
Incidence of infections proved low in eastern and western
Europe and the Americas, and high in Africa, Asia plus Oceania and,
somewhat unexpectedly, high also in southern Europe plus the
eastern Mediterranean. Earlier, we showed a similar pattern in
figures for overall incidence of illness and injury [3], a consequence
of the fact that infections represented 60% of all health problems.
Differences between health care services may influence the figures
within Europe: in countries with large numbers of tourists in
Table 4











Acute gastroenteritis 11,5444 (100) 8860 (76.7) 2684 (23.3) <0.05
Respiratory tract infections 10,475 (100) 9735 (92.9) 740 (7.1) <0.05
Ear infections 3843 (100) 3726 (97.0) 117 (3.0) <0.05
Dermatologic infections 1538 (100) 1362 (88.6) 176 (11.4) <0.05
Urogenital infections 1305 (100) 1191 (91.3) 114 (8.7) <0.05
Eye infections 955 (100) 955 (100.0) 0 <0.05
Systemic febrile infections 671 (100) 450 (67.1) 221 (32.9) <0.05
Other infections 55 (100) 46 (83.6) 9 (16.4) 0.513
All 30,386 (100) 26,325 (86.6) 4062 (13.4)
a A case was defined as a Finnish traveller abroad with one episode of illness,
handled by SOS International during 2010e2012. Anyone with several separate
episodes was counted more than once.
H. Siikam€aki et al. / Travel Medicine and Infectious Disease 15 (2017) 29e36 33southern Europe, private clinics directly contacting assistance or-
ganizations have evolved, whereas for countries with fewer private
hospitals, the proportion of cases reported to SOS may remain
smaller [3]. It seems, however, that this would only partly explain
the difference, since infection incidence in southern Europe plus
the eastern Mediterranean proved substantially higher than in
eastern plus western Europe. The highest incidence was for RTI, in
contrast to Africa and Asia, where TD ranked first. Although a low
risk for TD has been reported for southern Europe [7], we found aFig. 2. Percentages of diagnosis categories in various age groups among casesa abroad with
a A case was defined as a Finnish traveller abroad with one episode of illness, handled by SO
more than once.significantly higher incidence in southern Europe plus the eastern
Mediterranean than in eastern and western Europe or the Amer-
icas. Warmer climate and water exposure may readily explain the
higher incidence in dermatological, eye, and ear infections in
southern Europe plus the eastern Mediterranean, as compared to
eastern and western Europe. Interestingly, the incidence of sys-
temic febrile infections proved low in all regions alike.
A short incubation period explains in part the high incidence of
TD and RTI during travel. It should, however, be pointed out that TD
usually is a spontaneously resolving disease, and mild RTI does not
always require health care. Thus, the incidence of these infections,
although high in our study, still represents an underestimation of
their total burden among travellers.
4.2. Proportional morbidity
The most common infection type during travel was TD (38%),
consistent with findings on illness abroad [2,17e20] and after
travellers' return [2,10,13,14]. RTIs proved, however, nearly as
common (35%). Studies covering alsomilder diseases have reported
somewhat lower figures: in prospective studies, the rate of RTIs
during travel has ranged from 3 to 26% [2,17e20,27]. Sentinel sur-
veillance centres have reported figures between 8% and 21% after
travel [10,13,14]. In our study, TD cases were hospitalized more
often than were RTI cases. Duration of hospitalization for TD was
short, readily explained both by spontaneous recovery and quick
improvement after effective rehydration.infection diagnoses.
S International during 2010e2012. Anyone with several separate episodes was counted
Table 5









Acute gastroenteritis 11,544 6264 (37.0) 5280 (39.2) <0.05
Respiratory tract infections 10,475 6057 (35.8) 4418 (32.8) <0.05
Ear infections 3843 1714 (10.1) 2129 (15.8) <0.05
Dermatologic infections 1538 837 (4.9) 701 (5.2) 0.287
Urogenital infections 1305 1080 (6.4) 225 (1.7) <0.05
Eye infections 955 601 (3.5) 354 (2.6) <0.05
Systemic febrile infections 671 354 (2.1) 317 (2.4) 0.116
Other infections 55 28 (0.2) 27 (0.2) 0.471
All 30,386 16,935 (100) 13,451 (100)
a A case was defined as a Finnish traveler abroad with one episode of illness or
injury, handled by SOS International during 2010e2012. Anyone with several
separate episodes was counted more than once.
Table 6













Acute gastroenteritis 221 (43.4) 57 (35.8) 47 (58.9) 90 (48.4) 27 (32.1)
Acute respiratory
infections
90 (17.7) 13 (8.2) 10 (12.5) 31 (16.7) 36 (42.9)
Ear infections 75 (14.8)a 40 (25.2) 11 (13.8) 24 (12.9) 0
Dermatologic
infections
27 (5.3) 0 2 (2.5) 12 (6.5) 13 (15.5)
Urogenital infections 7 (1.4) 0 2 (2.5) 3 (1.6) 2 (2.4)
Eye infections 0 0 0 0 0
Systemic febrile
infections
86 (16.9) 49 (30.8)b 8 (10.0)c 26 (13.9)d 3 (3.6)
Other infections 3 (0.6) 0 0 0 3 (3.6)
All 509 (100) 159 (100) 80 (100) 186 (100) 84 (100)




H. Siikam€aki et al. / Travel Medicine and Infectious Disease 15 (2017) 29e3634Ear infections were the third largest infection group, consistent
with the high frequency of these infections in general, especially in
children, and thus also during travel. Some activities during travel,
such as those related to water recreation during holidays, may
serve as predisposing factors and partly explain the high frequency
of external otitis. Otitis media, by contrast, may occur anywhere but
is often associated with acute respiratory infections, which we
found to be frequent during travel. Patients with acute otitis media
or acute sinusitis should not fly until pressure in the middle ear or
sinuses has resolved [28,29]. Of those children having missed their
return flight due to infection, 25% had an ear infection. Of course, in
paediatric cases, an adult has to remain behind until the child is fit
to fly.4.2.1. Systemic febrile infections
The low incidence of systemic febrile infections in the present
study is consistent with other findings on health problems during
travel [2,22], yet contrasts with the substantially higher figures in
sentinel surveillance studies mostly detecting post-travel problems
in specialized centres [5,10,13e15]. While sentinel studies found
malaria as the most frequent cause of systemic febrile illness
[5,6,10,13e15], our data showed malaria in only 8 cases (1.2%). The
proportion of dengue (84 cases; 12.5%), by contrast, was similar to
that for febrile returned travellers (6e13%) [5,6,10]. The higher
proportion of dengue thanmalaria cases during travel may relate toits shorter incubation period. Indeed, diseases with a short incu-
bation period may manifest even during a short trip, while those
with longer incubation time may manifest after return and thus be
better presented in post-travel studies. Interestingly, during the
period of the present study, 190 post-travel malaria and 85 dengue
cases were reported in our nationwide surveillance system [30].4.2.2. Vaccine-preventable diseases
The proportionate morbidity of VPDs proved relatively low
(0.8%), a finding consistent with post-travel studies of surveillance
centres (0.9e2.3%) [9,10,14]. This probably reflects partly the actual
rarity of the exposure and partly the fairly good vaccine coverage
among Finnish travellers.
In contrast to studies reporting influenza as the most common
VPD among travellers [31,32], in our data, varicella ranked first
(49%), and influenza only second (27%), followed by herpes zoster
(20%). Varicella-zoster virus infections thus comprised a total of
69% of VPDs.
Varicella vaccination is included in the childhood vaccination
program at national level in only 6 of the 28 European Union
countries [33]. The Finnish national vaccination board has recom-
mended adding it to our vaccination program, but this recom-
mendation has yet to be implemented. As the incubation period of
varicella is 10e21 days, the infection may have already been con-
tracted before the trip. Developing symptoms of varicella abroad
has, however, important practical consequences for the return trip.
During the contagious stage of the disease, a patient with varicella
has to be isolated and is not allowed fly on commercial aircraft
[28,29]. According to aeromedical guidelines, the patient can fly ten
days after the onset of the rash if the crusts are dry and include no
fresh vesicles [28]. Of the varicella cases, 86% were children under
15 years of age, and 47% missed their return flight. If the child is
very young, because of the isolation, both parents also often have to
remain behind. Families with multiple children may have to post-
pone the return trip of the whole family for a considerable time.
Our results lead us to urge that varicella vaccine should be rec-
ommended before travel for all immunocompetent children and
adults who do not have a history of varicella infection or previous
vaccination or are uncertain of such history.
As for herpes zoster, a vaccine is available in many countries.
While not traditionally listed as a travellers' vaccine, these data
suggest that it could be considered for preventing varicella-zoster
virus reactivation during travel, especially in the elderly.
The situation for influenza is clear: annual vaccination against
seasonal influenza should be recommended to all travellers alike.
The fact that TD remains the most common infection in travellers
reminds us of the urgent need for vaccines against TD pathogens.
Likewise, the high proportion of RTIs demonstrates the lack of
vaccines against the most common respiratory pathogens.4.2.3. Sex and age
The proportion of inpatients was higher among men than
women, which accords with the greater proportion of TD cases
among men. In older age groups, the proportion of RTIs was higher,
but that of TD was lower than in the other groups. Both of these
findings actually demonstrate the elementary problem in pre-
senting proportionate morbidity: the percentages represent
numbers in relation to one another, not the actual incidence [24].
Based on these data, to draw a conclusion as to whether the
decrease in TD proportion with advancing age reflects only an in-
crease in the proportion of RTIs or vice versa, appears impossible. In
other studies, the risk for TD has proved highest in infants, toddlers,
and young adults [34e36].
H. Siikam€aki et al. / Travel Medicine and Infectious Disease 15 (2017) 29e36 354.2.4. Repatriation and deaths
As causes of death in travellers, infections have been reported to
be uncommon, as also shown here. Lunetta [37] analysed the
causes of death of Finnish travellers abroad during 1969e2007
finding that infections covered only 1.3%. Infections did not often
cause changes in travel plans either, which in part reflects the
benign course of the most common disease, TD, usually resolving
spontaneously within a few days [38,39].
4.3. Limitations and strengths
A few limitations of this study deserve discussion. The paedi-
atric populations could not be included in the incidence calcula-
tions because the denominator data of OSF did not include children
and, therefore, this group could only be included in figures
describing proportional morbidity.
The SOS database included no information on duration of and
reason for travel, or on itineraries of individual cases, preventing
any evaluation of these factors. Our data do not cover all illnesses
during travel. Firstly, the data lacked information on those ill
travellers who needed health care services but made no contact
with any insurance company or assistance organization while
abroad (either making a claim later or not using their insurance).
Nor did the data cover thosewithout travel insurance. Secondly, our
data do not cover the large group of travellers with mild symptoms
who did not use health care services abroad. Our recent prospective
study showed only 13% of travellers with health problems as con-
tacting healthcare providers [27]. Thirdly, as the study material
only covered infections during travel, it does not include those in-
fections acquired abroad but only becoming symptomatic after the
individual's return. These include especially diseases with a long
incubation period.
One of the strengths of the study is that the diagnoses were not
reported by travellers themselves after the trip but came directly
from clinicians treating the patient abroad. The original medical
reports were not available for the study, and thus we did not have
information on how the diagnoses were confirmed. Other strengths
include the exceptionally large size of the study population (30,086
cases) and the fact that it covers 95% of all Finnish cases abroad
handled by assistance organizations.
5. Conclusions
While our study does not cover the mildest cases, our data
represent quite comprehensively travellers' most serious in-
fections, those upon which pre-travel advice should especially
focus. Incidence of travellers' infections proved higher in southern
than in eastern and western Europe. TD and RTI proved nearly
equally common; the study further emphasizes the need for vac-
cines against both. Systemic febrile infections proved relatively
rare. Among infections targeted by currently available vaccines, the
most common proved to be varicella, with influenza ranking sec-
ond. Indeed, a history of varicella infection or vaccination should be
confirmed for all travelling children and adults, and seasonal
influenza vaccination should be recommended annually to all
travellers.
Funding sources
This research did not receive any specific grant from funding
agencies in the public, commercial, or not-for-profit sectors.
Authors' contributions
Study concept and design: HS, AK; acquisition of data HS, MF;analysis and interpretation of data HS, PK, AK; statistical analysis
HS, PK; drafting of the manuscript HS, AK; critical comments on the
manuscript PK, MF; final approval of the version published HS, PK,
MF, AK.
Conflict of interest
The authors state they have no conflicts of interest to declare.
Acknowledgments
We thank Jukka Ollgren (the National Institute for Health and
Welfare, Helsinki, Finland) for advice in statistical analysis.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.tmaid.2016.10.007.
References
[1] UNWTO world tourism organization. UNWTO tourism highlights. edition
2015.. http://mkt.unwto.org/en/publication/unwto-tourism-highlights-2015-
edition. 2015 [accessed 01.12.15].
[2] Hill DR. Health problems in a large cohort of Americans traveling to devel-
oping countries. J Travel Med 2000;7:259e66.
[3] Siikam€aki H, Kivel€a P, Fotopoulos M, Ollgren J, Kantele A. Illness and injury of
travellers abroad: Finnish nationwide data from 2010 to 2012, with in-
cidences in various regions of the world. Euro Surveill 2015;20:15e26.
[4] Leder K, Sundararajan V, Weld L, Pandey P, Brown G, Torresi J, et al. Respi-
ratory tract infections in travelers: a review of the GeoSentinel surveillance
network. Clin Infect Dis 2003;36:399e406.
[5] Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, et al.
Spectrum of disease and relation to place of exposure among ill returned
travelers. N Engl J Med 2006;354:119e30.
[6] Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from
the GeoSentinel surveillance network. Clin Infect Dis 2007;44:1560e8.
[7] Greenwood Z, Black J, Weld L, O'Brien D, Leder K, Von Sonnenburg F, et al.
Gastrointestinal infection among international travelers globally. J Travel Med
2008;15:221e8.
[8] Gautret P, Schlagenhauf P, Gaudart J, Castelli F, Brouqui P, von Sonnenburg F,
et al. Multicenter EuroTravNet/GeoSentinel study of travel-related infectious
diseases in Europe. Emerg Infect Dis 2009;15:1783e90.
[9] Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, et al.
Vaccine preventable diseases in returned international travelers: results from
the GeoSentinel surveillance network. Vaccine 2010;28:7389e95.
[10] Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, et al.
Travel and migration associated infectious diseases morbidity in Europe,
2008. BMC Infect Dis 2010;10:330.
[11] Schlagenhauf P, Chen LH, Wilson ME, Freedman DO, Tcheng D, Schwartz E,
et al. Sex and gender differences in travel-associated disease. Clin Infect Dis
2010;50:826e32.
[12] Gautret P, Gaudart J, Leder K, Schwartz E, Castelli F, Lim PL, et al. Travel-
associated illness in older adults (>60 y). J Travel Med 2012;19:169e77.
[13] Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, et al.
GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann
Intern Med 2013;158:456e68.
[14] Warne B, Weld LH, Cramer JP, Field VK, Grobusch MP, Caumes E, et al. Travel-
related infection in European travelers, EuroTravNet 2011. J Travel Med
2014;21:248e54.
[15] Schlagenhauf P, Weld L, Goorhuis A, Gautret P, Weber R, von Sonnenburg F,
et al. Travel-associated infection presenting in Europe (2008-12): an analysis
of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of
the pre-travel consultation. Lancet Infect Dis 2015;15:55e64.
[16] Liese B, Mundt KA, Dell LD, Nagy L, Demure B. Medical insurance claims
associated with international business travel. Occup Environ Med 1997;54:
499e503.
[17] Evans MR, Shickle D, Morgan MZ. Travel illness in British package holiday
tourists: prospective cohort study. J Infect 2001;43:140e7.
[18] Winer L, Alkan M. Incidence and precipitating factors of morbidity among
Israeli travelers abroad. J Travel Med 2002;9:227e32.
[19] Rack J, Wichmann O, Kamara B, Gunther M, Cramer J, Schonfeld C, et al. Risk
and spectrum of diseases in travelers to popular tourist destinations. J Travel
Med 2005;12:248e53.
[20] Fleck S, Jager H, Zeeb H. Travel and health status: a survey follow-up study.
Eur J Public Health 2006;16:96e100.
[21] Somer Kniestedt RA, Steffen R. Travel health insurance: indicator of serious
travel health risks. J Travel Med 2003;10:185e8.
H. Siikam€aki et al. / Travel Medicine and Infectious Disease 15 (2017) 29e3636[22] Leggat PA, Griffiths R, Leggat FW. Emergency assistance provided abroad to
insured travellers from Australia. Travel Med Infect Dis 2005;3:9e17.
[23] Lerdal A, Harding T, Kjolstad S. Illness and injury presenting to a Norwegian
travel insurance company's helpline. Travel Med Infect Dis 2007;5:165e70.
[24] Leder K, Wilson ME, Freedman DO, Torresi J. A comparative analysis of
methodological approaches used for estimating risk in travel medicine.
J Travel Med 2008;15:263e72.
[25] Official Statistics of Finland (OSF). Finnish travel. 2014. http://www.stat.fi/til/
smat/index_en.html. accessed 26.02.14.
[26] World Health Organization (WHO). International statistical classification of
diseases and related health problems 10th revision. 2014. http://www.who.
int/classifications/icd/en/. accessed 26.02.14.
[27] Vilkman K, Pakkanen SH, L€a€averi T, Siikam€aki H, Kantele A. Travelers' health
problems and behavior: prospective study with post-travel follow-up. BMC
Infect Dis 2016;16:328.
[28] The International Air Transport Association (IATA). IATA medical manual.
2016. http://www.iata.org/publications/Pages/medical-manual.aspx. accessed
21.08.16.
[29] Danish aeronautical medical association and SOS international. In: Klokker M,
Taudorf U, editors. Air travel and transportation of patients; 2016. http://
aeromedicalguidelines.com/forord-gb.html. accessed 21.08.16.
[30] National Institute for Health and Welfare. Infectious diseases in Finland. 2014.
http://www.thl.fi/en_US/web/infektiotaudit-en. accessed 26.02.2014.
[31] Mutsch M, Tavernini M, Marx A, Gregory V, Lin YP, Hay AJ, et al. Influenzavirus infection in travelers to tropical and subtropical countries. Clin Infect Dis
2005;40:1282e7.
[32] Askling HH, Lesko B, Vene S, Berndtson A, Bjorkman P, Blackberg J, et al.
Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis
2009;15:1805e8.
[33] European Centre for Disease Prevention and Control. Varicella vaccination in
the European union. 2015. www.ecdc.europa.eu/en/publications/guidance/
Pages/index.asp. accessed 01.01.15.
[34] Hoge CW, Shlim DR, Echeverria P, Rajah R, Herrmann JE, Cross JH. Epidemi-
ology of diarrhea among expatriate residents living in a highly endemic
environment. JAMA 1996;275:533e8.
[35] Steffen R, Tornieporth N, Clemens SA, Chatterjee S, Cavalcanti AM, Collard F,
et al. Epidemiology of travelers' diarrhea: details of a global survey. J Travel
Med 2004;11:231e7.
[36] Pitzinger B, Steffen R, Tschopp A. Incidence and clinical features of traveler's
diarrhea in infants and children. Pediatr Infect Dis J 1991;10:719e23.
[37] Lunetta P. Injury deaths among Finnish residents travelling abroad. Int J Inj
Contr Saf Promot 2010;17:161e8.
[38] Pitzurra R, Steffen R, Tschopp A, Mutsch M. Diarrhoea in a large prospective
cohort of European travellers to resource-limited destinations. BMC Infect Dis
2010;10:231.
[39] Belderok SM, van den Hoek A, Kint JA, Schim van der Loeff MF, Sonder GJ.
Incidence, risk factors and treatment of diarrhoea among Dutch travellers:
reasons not to routinely prescribe antibiotics. BMC Infect Dis 2011;11:295.
